Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis-Reference-Cited by-同舟云学术

Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis

Published:2019-02-12 Issue: Volume: Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Greenfield Ariele L.,Dandekar Ravi,Ramesh Akshaya,Eggers Erica L.,Wu Hao,Laurent Sarah,Harkin William,Pierson Natalie S.,Weber Martin S.,Henry Roland G.^ORCID,Bischof Antje^ORCID,Cree Bruce A.C.^ORCID,Hauser Stephen L.^ORCID,Wilson Michael R.^ORCID,von Büdingen H.-Christian^ORCID

Funder

National Multiple Sclerosis Society

National Institute of Neurological Disorders and Stroke

Valhalla Foundation

Friends of the Multiple Sclerosis Research Group at UCSF

Rachleff Family Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

http://insight.jci.org/articles/view/126599/files/pdf

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes;Acta Neurologica Belgica;2024-08-03

2. Single-cell profiling indicates a high similarity between immune cells in the cerebrospinal fluid and in meningeal ectopic lymphoid tissue in experimental autoimmune encephalomyelitis;Frontiers in Immunology;2024-06-12

3. Lymphocytic infiltration in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-05

4. An autoantibody signature predictive for multiple sclerosis;Nature Medicine;2024-04-19

5. B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases;Clinical Reviews in Allergy & Immunology;2024-03-09